Nephrologist
Director – Nephrology and Transplant Services24 years
Fortis Hospitals
Mumbai
Dr. Haresh Dodeja is the Director of Nephrology and Transplant Services at Fortis Hospital, Mulund, Mumbai. He is an experienced Nephrologist with clinical expertise in kidney diseases, dialysis, kidney transplantation and the management of complex renal conditions. His special interests include renal obstetrics and long-term care for kidney transplant recipients.
Dr. Dodeja completed his MD in Medicine from Grant Medical College, Mumbai, followed by DNB training in Nephrology at Jaslok Hospital and Research Centre. He subsequently undertook a Royal College-sponsored Clinical Fellowship at Leicester General Hospital in the United Kingdom, where he received specialist training in nephrology and transplant-related care.
His clinical expertise covers general nephrology, haemodialysis, peritoneal dialysis, continuous renal replacement therapy and kidney transplant medicine. He evaluates patients with acute or chronic kidney disorders and develops management plans based on kidney function, underlying disease, associated medical conditions and treatment requirements.
Dr. Haresh Dodeja has particular experience in kidney transplant evaluation and long-term post-transplant management. He has been associated with significant developments in living donor, deceased donor and ABO-incompatible kidney transplantation in the Mulund region. His clinical work also includes managing kidney-related complications during pregnancy.
His additional procedural training includes ultrasound-guided kidney biopsy and the insertion of long-term dialysis catheters. He has contributed to nephrology education and medical publications, including work associated with an Oxford nephrology reference publication. He also received the Dr. P. N. Berry Scholarship in 2003 for advanced medical training in the United Kingdom.
Patients seeking a nephrologist in Mumbai for chronic kidney disease, dialysis, transplant-related care or kidney problems during pregnancy can consult Dr. Haresh Dodeja through his listed hospital and clinic affiliations. Current consultation arrangements and the availability of individual services should be confirmed directly.
Chronic kidney disease involves persistent abnormalities in kidney structure or function. Management focuses on identifying the underlying cause, monitoring kidney function and reducing the risk of progression. Treatment may include blood pressure control, diabetes management, dietary guidance and medications tailored to the patient's condition.
Acute kidney injury is a sudden decline in kidney function that may result from dehydration, infection, medication effects or other serious illnesses. Management involves identifying the cause, monitoring fluid and electrolyte balance and providing supportive care. Selected patients may require temporary dialysis.
Haemodialysis is a kidney replacement treatment that removes waste products and excess fluid from the blood using a dialysis machine. It may be required for advanced kidney failure or certain acute conditions. Treatment schedules and vascular access requirements depend on the patient's clinical needs.
Peritoneal dialysis uses the lining of the abdominal cavity as a membrane for removing waste products and excess fluid. Dialysis solution is introduced through a catheter and exchanged according to a prescribed schedule. It may be a suitable alternative to haemodialysis for selected patients.
Continuous renal replacement therapy provides gradual dialysis and fluid removal for selected critically ill patients, particularly those with unstable blood circulation. It is generally performed in intensive care settings. Treatment requires careful monitoring of fluid balance, electrolytes, anticoagulation and kidney-related complications.
Continuous ambulatory peritoneal dialysis is a form of peritoneal dialysis in which fluid exchanges are performed manually throughout the day. It does not require a dialysis machine for each exchange. Patients need training in infection prevention, catheter care and the prescribed dialysis technique.
Kidney transplant evaluation assesses whether transplantation may be appropriate for a patient with advanced kidney failure. The process can involve cardiovascular assessment, infection screening, donor compatibility testing and other investigations. A multidisciplinary transplant team considers the medical benefits and risks before proceeding.
Patients who receive a kidney transplant require long-term monitoring of graft function, immunosuppressive medication and possible complications. Follow-up may include blood tests, infection prevention and assessment for rejection. Nephrologists coordinate ongoing care to support the health of the transplanted kidney.
ABO-incompatible kidney transplantation involves transplantation between certain donors and recipients with different blood groups. It requires specialist protocols to reduce immune-related risks and careful monitoring before and after surgery. Eligibility and treatment decisions are determined by a multidisciplinary transplant team.
Renal obstetrics focuses on kidney-related medical issues during pregnancy, including pre-existing kidney disease and pregnancy-associated changes in renal function. Management requires close collaboration between nephrologists and obstetric specialists to monitor maternal health, blood pressure, kidney function and fetal wellbeing.
An ultrasound-guided kidney biopsy involves obtaining a small sample of kidney tissue using imaging guidance. It may help diagnose selected glomerular and other renal diseases. The procedure requires assessment of bleeding risk, blood pressure and medical suitability before the biopsy is performed.
A Permacath is a tunnelled central venous catheter used for haemodialysis access when clinically indicated. Placement requires sterile technique and appropriate vascular assessment. Patients need ongoing catheter care and monitoring for infection, thrombosis or mechanical complications.
Glomerular diseases affect the kidney's filtering structures and may cause proteinuria, blood in the urine or reduced kidney function. Evaluation can include laboratory tests, imaging and sometimes kidney biopsy. Management depends on the specific diagnosis and the extent of kidney involvement.
High blood pressure can contribute to kidney damage, while kidney disorders can also cause hypertension. Management involves monitoring blood pressure, kidney function and urine abnormalities. Treatment may include medications, lifestyle measures and management of other cardiovascular or metabolic risk factors.
MD (Medicine), DNB (Nephrology), MNAMS
Chronic Kidney Disease Management, Acute Kidney Injury Management, Haemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy (CRRT), Continuous Ambulatory Peritoneal Dialysis (CAPD), Kidney Transplant Evaluation, Post-Kidney Transplant Care, ABO-Incompatible Kidney Transplantation Management, Living Donor Kidney Transplant Care, Deceased Donor Kidney Transplant Care, Renal Obstetrics, Kidney Disease in Pregnancy, Ultrasound-Guided Kidney Biopsy, Permacath Insertion, Glomerular Disease Assessment, Proteinuria Evaluation, Hypertension-Related Kidney Disease Management.
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Haresh Dodeja
He specialises in Nephrology and Kidney Transplant Medicine, including kidney disease, dialysis and post-transplant management.
He holds an MD in Medicine, DNB in Nephrology, MNAMS and a Royal College-sponsored nephrology fellowship credential.
Fortis displays 24 years, although its biography states more than 25 years. The current figure should be confirmed.
Yes. His professional profile identifies expertise in haemodialysis, peritoneal dialysis, CRRT and CAPD.
Yes. He is Director of Nephrology and Transplant Services and has documented experience in long-term transplant patient management.
Contact us for personalized help or to schedule an appointment.